Figure 4

(A) number of sequences, out of fifteen identified at full sequencing depth, that matched anti-SARS-CoV-2 sequences (BLAST hits) and their presence across different variants. Note: The values in the matrix do not add up to fifteen, as one sequence can be present in multiple variants. (B) number of sequences identified at full sequencing depth compared to those identified at a sequencing depth of 50 million reads. We differentiate between sequences present in seronegative samples and those absent in seronegative samples. (C) shows a similar comparison as (B) between sequences identified at full sequencing depth compared to sequences identified at a sequencing depth of 10 million reads.